Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.

Nevertheless, the timing is notable. As QuantumScape executes a strategically symbolic move to the Nasdaq to align itself with other technology stocks, a significant insider's partial sale sends an ...

Real estate stocks and funds are set to surge as investors anticipate lower interest rates and inflation. 3 stocks to watch in 2026: Rocket Companies, Redfin, and Zillow.

MercadoLibre's robust fintech growth and profitability amid Latin America's economic risks. Click here to read my latest analysis of MELI stock.

Melech’s push to withdraw Israel from the WHO drew backlash from health leaders, who warned of risks to public health and international ties.